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Specific Mode of Transmission
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Chronic hepatitis C infection is one of the main causes of 
chronic liver disease, cirrhosis and hepatocellular carcinoma. 
Although means of eradicating hepatitis C virus (HCV) are on 
their way, an effective HCV vaccine is yet to be discovered. Cur-
rent strategies for preventing HCV are to be closely related to 
the understanding of regional epidemiology and possible mode 
of infection.
South Korea is considered to be HCV low prevalent area re-
porting the general prevalence rate less than 1.5%.1 However, 
Kwon et al.2 reported that there are noticeable differences in 
HCV distribution among the regions and counties, highest be-
ing age-adjusted prevalence greater than 3.5% in a county of 
Busan, southwest coast of South Korea. Considering the ap-
proximated HCV prevalence in Korea being 0.12% to 0.13%, 
the prevalence of 3.5% is stunning. This alarming figure should 
raise a systematic investigation seeking the possible route of 
infection and an initiation of education program for the general 
population on HCV infection and prevention. 
The prevalence of HCV seems to vary according to the study 
population and design since large proportion of HCV infected 
population is asymptomatic.3 Kwon et al.2 made use of the 
National Health Insurance data which naturally included only 
those who sought the medical assistances and reported the 
prevalence that is much lower than that of the previous reports. 
The figure presented by Kwon et al.2 is closer to HCV RNA 
prevalence among Korean blood donors between February 2005 
and December 2009 which reported the prevalence of 0.16%.4 
On the other hands, anti-HCV prevalence among health check-
up examinees are reported to be 0.78% to 1.29%.5,6 Prevalence 
approximated by anti-HCV positivity tends to be exaggerated 
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since persons with past infection after recovery and with false 
anti-HCV positive must be included in the figure. However, the 
most recently performed investigation6 using serologic data of 
health check-up participants demonstrated the similar regional 
variations as the study by Kwon et al.2 Although the figures 
from anti-HCV positivity study were generally larger than that 
from the National Health Insurance data, both studies reported 
Jeonnam and Busan having highest age-adjusted HCV preva-
lence in South Korea. Being southern coastal part of Korea, no 
apparent common factors for high HCV infection are noticeable 
between two regions. Careless contemplation about possible 
explanation for the higher prevalence without scientific evi-
dences may result in biased opinions on those regions. Instead, 
epidemiologic studies seeking mode of infections related to the 
geographical, cultural, and medical factors should be initiated 
to prevent the further infection. It should be emphasized that 
although study by Kwon et al.2 only concentrated on evaluat-
ing the prevalence, their results on regional variations which 
is in accordance with the previous study provide a ground for 
the further investigation on epidemiological study over route of 
transmission. 
Investigating risk factors and mode of transmission for HCV 
is not a straightforward work since acute HCV infection often 
passes asymptomatic.7 Strenuous task it may be, it is a very im-
portant especially for an infectious disease where active means 
of immunization is not feasible. A recent prospective study 
included 1,173 anti-HCV Ab positive persons and underwent 
careful survey and data collection processes to identify risk fac-
tor in the HCV cohort.8 The study presented use of illicit intra-
venous drugs, experiencing needle stick injury, receiving trans-
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fusion before 1995 and tattooing as the meaningful risk factors. 
These risk factors seem to be similar to that of other parts of the 
world. However, if Korean cultural health behaviors were to be 
taken account, risk factors might have been more diverse and 
valuable. As Kwon et al.2 discussed in their work, residents of a 
specific part of Korea often undergo a type of phlebotomy called 
“Buhwang” as alternative medicine. Acupuncture by unlicensed 
personnel can be another risk factor in Korea. 
With Kwon et al.2 validating previous work showing regional 
variations on HCV prevalence, epidemiologic studies consider-
ing the regional culture and habits should ensue in order to 
develop effective means of counselling for HCV prevention. 
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